Europe — EMA

Olmesartan Medoxomil Glenmark Pharmaceuticals Europe

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Glenmark Pharmaceuticals Europe, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Glenmark Pharmaceuticals Europe, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to manage high blood pressure in adults. GNH USA supplies Olmesartan Medoxomil Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil works by target the renin‑ren‑angi pathway to lower blood pressure in patients with hypertension.

- Hypertension: Reduces systolic and diastolic blood pressure, decreasing cardiovascular risk. - Heart : - - Ch - - - - -

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →